找到16记录 | 不满意,请使用左下搜索矩阵
排序: 相关性 发表日期 影响因子

Co-stimulatory tumor necrosis factor receptors (TNFRs) can sculpt the responsiveness of T cells r...

关键词: 4-1BB    CD134    CD137    CD27    CD357    FcγR    GITR    OX40    TNFR    TNFRSF    TRAF    antibodies    cancer    clinical trials    co-stimulation    human    immunotherapy    oncology   
期刊:Hum Antibodies  影响因子:0.0  发表日期: 20170101  PMID: 28085016 


BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by T-cell-d...

关键词: CD134    IFN-γ    IL-22    PD-1    SLE   
期刊:Eur J Med Res  影响因子:1.736  发表日期: 20190722  PMID: 31331400 


Combination immunotherapies utilizing complementary modalities that target distinct tumor attribu...

关键词: 4-1BB    CD134    CD137    Cancer immunotherapy    Costimulation    OX40   
期刊:Cancer Immunol Immunother  影响因子:0.0  发表日期: 20180401  PMID: 29327109 


Head and neck squamous cell carcinoma (HNSCC) is the sixth leading incident cancer worldwide. In ...

关键词: CD134    Gene polymorphisms    HNSCC    OX40    rs17568    rs2298211   
期刊:Mol Biol Rep  影响因子:2.107  发表日期: 20190328  PMID: 30923998 


BACKGROUND: CD134 (OX40), which is a cellular receptor for human herpesvirus-6B (HHV-6B) and expr...

期刊:J Clin Virol  影响因子:3.02  发表日期: 20180501  PMID: 29494951 


The ability of T cells to recognize a vast array of antigens enables them to destroy tumor cells ...

关键词: CD134    CD137    CD4 T cell    dual costimulation    immunotherapy   
期刊:Oncoimmunology  影响因子:5.333  发表日期: 20130101  PMID: 23482891 


Tumor-infiltrating regulatory T cells (Tregs) promote immune evasion and are associated with poor...

关键词: CD134    CD80    GARP    GITR    LRRC32    OX40    RGS1    TNFRSF18    TNFRSF4    inherited variants    ovarian cancer    regulatory T cells   
期刊:Oncoimmunology  影响因子:5.333  发表日期: 20130601  PMID: 23894717 


Human herpesvirus 6B (HHV-6B) commonly reactivates after umbilical cord blood transplantation (UC...

期刊:J Infect Dis  影响因子:5.045  发表日期: 20161215  PMID: 27703035 


    相关搜索: